SCHEMBL4583701

SCHEMBL4583701

NS(=O)(=O)c1ccccc1-n1cnnn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.52
LMNA P02545 1/20 0.51
ALDH1A1 P00352 6/20 0.50
NPSR1 Q6W5P4 2/20 0.50
NOTUM Q6P988 1/20 0.46
CA2 P00918 6/20 0.45
CA1 P00915 4/20 0.45
CA12 O43570 3/20 0.45
CA9 Q16790 3/20 0.45
CA7 P43166 3/20 0.43
RAB9A P51151 1/20 0.42
MAPK1 P28482 1/20 0.41
KDM4E B2RXH2 3/20 0.41
CYP2C9 P11712 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
RCE1 Q9Y256 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4582472 0.84 GAA (0.62) GAALMNAALDH1A1NPSR1RAB9A
SCHEMBL14921284 0.83 ALDH1A1 (0.50) GAALMNAALDH1A1NPSR1NOTUM
SCHEMBL28052069 0.83 ALDH1A1 (0.50) LMNAALDH1A1NPSR1NOTUMMAPK1
SCHEMBL12615992 0.78 ALDH1A1 (0.68) ALDH1A1NPSR1NOTUMKDM4ENPC1
SCHEMBL5602630 0.77 CA2 (0.45) NOTUMCA2CA1CA12CA9
SCHEMBL29718670 0.73 CRHBP (0.46) LMNAALDH1A1CA2CA1CA12
SCHEMBL4759627 0.73 CRHBP (0.46) LMNAALDH1A1CA2CA1CA12
SCHEMBL8109135 0.73 ALDH1A1 (0.58) ALDH1A1NPSR1NOTUMMAPK1KDM4E
SCHEMBL30084182 0.73 ALDH1A1 (0.58) GAALMNAALDH1A1NPSR1NOTUM
SCHEMBL5330184 0.73 ALDH1A1 (0.58) GAALMNAALDH1A1NPSR1NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP claimed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO claimed
US-8362017-B2 N-[5-chloro-2-(methyloxy)phenyl]-2-{[3-(1H-tetrazol-1-yl)phenyl]oxy}acetamide; antiproliferative agents; protein kinase inhibitors; drug screening EXELIXIS, INC. (US) 2013-01-29 US disclosed
US-20080096892-A1 C-Kit Modulators And Methods Of Use EXELIXIS, INC. (US) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096892-A1 C-Kit Modulators And Methods Of Use KIT, PRKCH, PRKCB GAA 954/4885LMNA 922/4885ALDH1A1 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.